Litcius/Paper detail

High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial

Roshal R. Patel, Kewen He, Hampartsoum B. Barsoumian, Joe Y. Chang, Chad Tang, Vivek Verma, Nathan Comeaux, Stephen G. Chun, Saumil Gandhi, Mylene T. Truong, Jeremy J. Erasmus, David S. Hong, Percy P. Lee, Matthew S. Ning, Quynh‐Nhu Nguyen, John V. Heymach, Mehmet Altan, George R. Blumenschein, Frank V. Fossella, Duygu Sezen, Dawei Chen, Brett W. Carter, Michael A. Davies, Isabella C. Glitza, Adi Diab, Renata Ferrarotto, Maria E. Cabanillas, Ying Yuan, Shalin Shah, Edwin R. Parra, Baohua Sun, María Angélica Cortez, James W. Welsh

2021Radiotherapy and Oncology93 citationsDOIOpen Access PDF

Topics & Concepts

MedicineClinical endpointResponse Evaluation Criteria in Solid TumorsInternal medicineToxicityProgressive diseaseRadiation therapyGastroenterologyNuclear medicinePhases of clinical researchLesionUrologyChemotherapyOncologyClinical trialSurgeryCancer Immunotherapy and BiomarkersEffects of Radiation ExposureRadiation Therapy and Dosimetry